Published in Pediatr Infect Dis J on April 01, 2000
TcpF is a soluble colonization factor and protective antigen secreted by El Tor and classical O1 and O139 Vibrio cholerae serogroups. Infect Immun (2005) 1.09
Pertussis vaccination for health care workers. Clin Microbiol Rev (2008) 0.92
Pertussis immunization for adolescents: What are we waiting for? Paediatr Child Health (2001) 0.84
Progress in the Diagnosis, Prevention, and Treatment of Pertussis. Curr Infect Dis Rep (2003) 0.84
Pertussis immunization for adolescents: What are we waiting for? Can J Infect Dis (2001) 0.75
A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev (1993) 9.28
Drinking to regulate positive and negative emotions: a motivational model of alcohol use. J Pers Soc Psychol (1995) 8.48
A rapid method for localized mutagenesis of yeast genes. Yeast (1992) 7.79
Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript. Genes Dev (1994) 7.57
Degradation of mRNA in eukaryotes. Cell (1995) 6.81
A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer (1976) 6.48
An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature (1996) 6.15
Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell (1987) 6.08
Premature translational termination triggers mRNA decapping. Nature (1994) 6.05
Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res (1992) 5.98
Yeast Sm-like proteins function in mRNA decapping and decay. Nature (2000) 5.95
The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell (2001) 5.86
Turnover mechanisms of the stable yeast PGK1 mRNA. Mol Cell Biol (1995) 5.83
Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1990) 5.47
A terminological and ontological analysis of the NCI Thesaurus. Methods Inf Med (2005) 5.11
The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J (1999) 5.08
The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA (2001) 4.80
Hair analysis for drugs: technological break-through or ethical quagmire? Addiction (1993) 4.60
Yeast exosome mutants accumulate 3'-extended polyadenylated forms of U4 small nuclear RNA and small nucleolar RNAs. Mol Cell Biol (2000) 4.57
DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell (1993) 4.57
Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1999) 4.35
Mechanisms and control of mRNA turnover in Saccharomyces cerevisiae. Microbiol Rev (1996) 4.34
Mutations affecting stability and deadenylation of the yeast MFA2 transcript. Genes Dev (1992) 4.20
Multiple functions for the poly(A)-binding protein in mRNA decapping and deadenylation in yeast. Genes Dev (1995) 4.15
Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol Cell (2001) 4.12
Method for Making Filters Transmitting the Near Ultraviolet and Absorbing Visual Light. Science (1946) 4.01
National asthma attack audit 1991-2. General Practitioners in Asthma Group. BMJ (1993) 3.97
A small segment of the MAT alpha 1 transcript promotes mRNA decay in Saccharomyces cerevisiae: a stimulatory role for rare codons. Mol Cell Biol (1993) 3.91
A highly polymorphic locus very tightly linked to the Huntington's disease gene. Nature (1988) 3.90
Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr (1994) 3.78
Quality control of mRNA 3'-end processing is linked to the nuclear exosome. Nature (2001) 3.69
Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods (1985) 3.67
Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol Cell Biol (1996) 3.58
Biochemical characterization of human collagenase-3. J Biol Chem (1996) 3.52
Stress and alcohol use: moderating effects of gender, coping, and alcohol expectancies. J Abnorm Psychol (1992) 3.46
The Puf3 protein is a transcript-specific regulator of mRNA degradation in yeast. EMBO J (2000) 3.38
Differential effects of translational inhibition in cis and in trans on the decay of the unstable yeast MFA2 mRNA. J Biol Chem (1994) 3.37
Mutations in conserved intron sequences affect multiple steps in the yeast splicing pathway, particularly assembly of the spliceosome. EMBO J (1986) 3.35
Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2). Diabet Med (2005) 3.21
Biosynthesis of penicillin N and cephalosporin C. Antibiotic production and other features of the metabolism of Cephalosporium sp. Biochem J (1967) 3.12
Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet (1982) 3.11
Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis (2001) 3.11
mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol Cell Biol (2000) 3.06
Antecedents and outcomes of work-family conflict: testing a model of the work-family interface. J Appl Psychol (1992) 3.01
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
Mechanisms of mRNA degradation in eukaryotes. Trends Biochem Sci (1994) 2.96
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med (1987) 2.91
Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM. Diabetes Care (1997) 2.84
Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol (1996) 2.84
Isolation and characterization of Dcp1p, the yeast mRNA decapping enzyme. EMBO J (1998) 2.82
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 2.82
Orbital blowout fractures: a ten-year survey. Plast Reconstr Surg (1967) 2.76
A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature (1995) 2.75
Mechanisms of mRNA surveillance in eukaryotes. Annu Rev Genet (1999) 2.73
The exosome: a proteasome for RNA? Cell (1999) 2.72
Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol Cell Biol (2000) 2.71
Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol (1995) 2.69
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem Pharmacol (1996) 2.67
Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae. Annu Rev Biochem (2000) 2.66
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Changes in tonsillectomy rates associated with feedback and review. Pediatrics (1977) 2.60
Acute ileus in myxoedema. Br Med J (1977) 2.57
A point mutation in the conserved hexanucleotide at a yeast 5' splice junction uncouples recognition, cleavage, and ligation. Cell (1985) 2.56
Passive immunization of hamsters against experimental infection with the Lyme disease spirochete. Infect Immun (1986) 2.55
The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer (2007) 2.48
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem (1996) 2.45
Three conserved members of the RNase D family have unique and overlapping functions in the processing of 5S, 5.8S, U4, U5, RNase MRP and RNase P RNAs in yeast. EMBO J (2000) 2.44
Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol (1994) 2.43
Analysis of the yeast genome: identification of new non-coding and small ORF-containing RNAs. Nucleic Acids Res (1997) 2.40
Coping, expectancies, and alcohol abuse: a test of social learning formulations. J Abnorm Psychol (1988) 2.38
Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut (1968) 2.38
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Is there a role for benefit-cost analysis in environmental, health, and safety regulation? Science (1996) 2.32
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology (2001) 2.27
Clustering of multiallele DNA markers near the Huntington's disease gene. J Clin Invest (1989) 2.25
Assessment of a universal, school-based hepatitis B vaccination program. JAMA (1995) 2.23
Measurement of mRNA decay rates in Saccharomyces cerevisiae. Methods Enzymol (1991) 2.17
Aberrant mRNAs with extended 3' UTRs are substrates for rapid degradation by mRNA surveillance. RNA (1999) 2.15
Functions of Lsm proteins in mRNA degradation and splicing. Curr Opin Cell Biol (2000) 2.14
Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet (1989) 2.12
Myenteric plexus in Hirschsprung's disease. Gut (1967) 2.11
Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst (1999) 2.11
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
Direct observation of one-dimensional diffusion and transcription by Escherichia coli RNA polymerase. Biophys J (1999) 2.09
Laparoscopy in the surgical treatment of rectal cancer in Germany 2000-2009. Colorectal Dis (2012) 2.07
Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr Opin Cell Biol (1995) 2.06
Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A (1996) 2.06
21st-century evolution of Greenland outlet glacier velocities. Science (2012) 2.05
Development of a compact fast CCD camera and resonant soft x-ray scattering endstation for time-resolved pump-probe experiments. Rev Sci Instrum (2011) 2.05
Evidence of cadmium toxicity in a population living in a zinc-mining area. Pilot survey of Shipham residents. Lancet (1979) 2.05
Ambulatory blood pressure in pregnancy: comparison of the Spacelabs 90207 and Accutracker II monitors with intraarterial recordings. Am J Obstet Gynecol (1995) 2.03
Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology (2000) 2.02
Ocular hypertelorism and pseudohypertelorism. Advances in surgical treatment. Plast Reconstr Surg (1970) 2.01
Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer (1995) 2.00
A trans-acting suppressor restores splicing of a yeast intron with a branch point mutation. Genes Dev (1987) 1.99
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents. Antimicrob Agents Chemother (1987) 1.98
Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol (1996) 1.95
Active immunization of hamsters against experimental infection with Borrelia burgdorferi. Infect Immun (1986) 1.94